Our Vision
Triple Hair is a clinical-stage biopharmaceutical company working to redefine the standard of care in androgenic alopecia, a disease that has long had partial treatments but no real solution. Where existing therapies target a single cause, we develop combination therapies designed to address the disease as it actually presents: multifactorial, and needing several mechanisms working together. Our approach is built on this insight, on rigorous clinical science and on proprietary IP.
Leadership and advisors
Built by people who have done this before
Triple Hair pairs experienced biopharma leadership with regulatory and clinical depth to accelerate our pipeline execution and to move TH07 through late-stage development and toward market.
Houfar Sekhavat, MD
Founder and Director
Jean-Philippe Gravel, MBA
President, CEO and Director
Chanèle Dumontier, CPA
Chief Financial Officer
Jean Lachapelle, M. Sc.
VP Operations
Guy Chamberland, Ph.D.
VP of Regulatory Affairs
Meenu Grover, PhD
VP Medical Affairs
RECENT PUBLICATIONS
Corporate and scientific news
Behind Triple Hair is a team of dedicated scientists, clinicians and innovators who refuse to settle for incremental progress. Together, they are building a development pipeline led by TH07, with the aim of redefining what is possible in hair loss care.
